Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
50
NCT07099066
Generation of Cell Banks and Biomarker Isolation From Patients With Amyotrophic Lateral Sclerosis (ALS) (HCD-SLA)
Phase: N/A
Role: Lead Sponsor
Start: Sep 1, 2025
Completion: Jun 30, 2026